Compounds > (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Page last updated: 2024-11-08

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Vomiting

(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Vomiting in 1 studies

(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride: A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beleslin, DB1
Strbac, M1
Jovanović-Mićić, D1
Samardzić, R1
Nedelkovski, V1

Other Studies

1 other study available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Vomiting

ArticleYear
Area postrema: cholinergic and noradrenergic regulation of emesis. A new concept.
    Archives internationales de physiologie et de biochimie, 1989, Volume: 97, Issue:1

    Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Brain Stem; Cats; Cer

1989